Viewing Study NCT01280630



Ignite Creation Date: 2024-05-05 @ 11:14 PM
Last Modification Date: 2024-10-26 @ 10:30 AM
Study NCT ID: NCT01280630
Status: COMPLETED
Last Update Posted: 2012-02-01
First Post: 2011-01-20

Brief Title: Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome ACS Patients
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: A Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome ACS Patients in India
Status: COMPLETED
Status Verified Date: 2012-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TRACE
Brief Summary: TRACE is a Multicentre Retrospective Study planned to gather follow up data for a period of 1 year in order to understand anti-thrombotic management patterns and outcomes of Acute Coronary Syndrome patients in India

This retrospective study is designed to provide a rapid and quick analysis of the existing database of ACS patients So as to ensure quality check in the study a pilot study will be conducted with around 500 patients at 10 centres across India and based on the meaningful results of the pilot study full retrospective multi-centric study will be initiated at various selected centres across India This study will use available registry data from a defined time period of Jan 2007-Dec 2009
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None